Please assess the completion status of the following clinical trial:

Trial Title: Blood Flow Restriction Therapy in Patellofemoral Pain Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* ASA class I-II~* Diagnosed with patellofemoral pain syndrome~Exclusion Criteria:~* Patients with confirmed radiographic evidence explaining knee pain~* Legally incompetent or mentally impaired (e.g. minors, Alzheimer's subjects, dementia, etc.)~* Younger than 18 years of age or older than 65~* Any patient considered a vulnerable subject~* Patients with impaired circulation, peripheral vascular compromise, Previous revascularization of the extremity, or severe hypertension~* Patients with Sickle cell anemia or venous thromboembolism~* Patients with Sickle cell anemia or venous thromboembolism~* Patients with cancer or Lymphectomies~* Patients with increased intracranial pressure

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Patients with Patellopain syndrome with Cuff (Type: EXPERIMENTAL): Patient will be prescribed to 6 weeks of physical therapy with a cuff around the affected leg during exercises
- Patients with Patellopain syndrome with Placebo Cuff (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).